Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 240

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 1B
Chunk 240
---
 of the income tax provision. We have no accrued interest and penalties as of December 31, 2024 and 2023 due to available tax losses. Our significant jurisdictions are the U.S. federal jurisdiction and the California state jurisdiction. All of our tax years remain open to examination by the U.S. federal and California tax authorities. We also file in other state, local and foreign jurisdictions in which we operate, and such tax years remain open to examination. As of December 31, 2024, we are not permanently reinvested with respect to its foreign earnings and have not recorded deferred income taxes and withholding taxes as these taxes are immaterial to the financial statements. 

12.Supplemental Balance Sheet InformationInventoriesInventories consist of the following as of each period: 

        December 31,

        December 31,

        2024

        2023

        (in thousands)

        Raw Materials
         
        $
        964

        $
        2,335

        Work-in-process

        9,691

        7,371

        Total inventories
         
        $
        10,655

        $
        9,706

      Property and equipment, netProperty and equipment consisted of the following as of each period end: 

        December 31,

        December 31,

        2024

        2023

        (in thousands)

        Leasehold improvements
         
        $
        930

        $
        904

        Lab equipment

        14,446

        15,540

        Machinery and equipment

        572

        572

        Computer equipment and software

        1,381

        1,279

        Furniture and fixtures

        1,272

        1,272

        Construction in progress

        —

        158

        Property and equipment, gross

        18,601

        19,725

        Less: accumulated depreciation

        (17,307
        )

        (15,869
        )

        Property and equipment, net
         
        $
        1,294

        $
        3,856

      Depreciation expense was $2.7 million and $3.7 million for the years ended December 31, 2024 and 2023, respectively. 

129

Other current liabilitiesOther current liabilities consisted of the following as of each period end:

        December 31,

        December